MiRNA-Mediated Fibrosis in the Out-of-Target Heart following Partial-Body Irradiation.
Raman spectroscopy
abscopal effect
cardiac fibrosis
miR-1
miRNome
mir-133a
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Jul 2022
16 Jul 2022
Historique:
received:
24
05
2022
revised:
08
07
2022
accepted:
14
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Recent reports have shown a link between radiation exposure and non-cancer diseases such as radiation-induced heart disease (RIHD). Radiation exposures are often inhomogeneous, and out-of-target effects have been studied in terms of cancer risk, but very few studies have been carried out for non-cancer diseases. Here, the role of miRNAs in the pathogenesis of RIHD was investigated. C57Bl/6J female mice were whole- (WBI) or partial-body-irradiated (PBI) with 2 Gy of X-rays or sham-irradiated (SI). In PBI exposure, the lower third of the mouse body was irradiated, while the upper two-thirds were shielded. From all groups, hearts were collected 15 days or 6 months post-irradiation. The MiRNome analysis at 15 days post-irradiation showed that miRNAs, belonging to the myomiR family, were highly differentially expressed in WBI and PBI mouse hearts compared with SI hearts. Raman spectral data collected 15 days and 6 months post-irradiation showed biochemical differences among SI, WBI and PBI mouse hearts. Fibrosis in WBI and PBI mouse hearts, indicated by the increased deposition of collagen and the overexpression of genes involved in myofibroblast activation, was found 6 months post-irradiation. Using an in vitro co-culture system, involving directly irradiated skeletal muscle and unirradiated ventricular cardiac human cells, we propose the role of miR-1/133a as mediators of the abscopal response, suggesting that miRNA-based strategies could be relevant for limiting tissue-dependent reactions in non-directly irradiated tissues.
Identifiants
pubmed: 35884524
pii: cancers14143463
doi: 10.3390/cancers14143463
pmc: PMC9323333
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : SEPARATE project, Euratom Research and training programme 2014-2018, in the framework of the CONCERT EJP
ID : 662287
Références
Radiat Oncol J. 2018 Jun;36(2):85-94
pubmed: 29983028
Ther Adv Med Oncol. 2020 Jul 30;12:1758835920918499
pubmed: 32821294
J Cell Mol Med. 2020 Jul;24(14):7717-7729
pubmed: 32536032
PLoS One. 2013;8(2):e57052
pubmed: 23451141
Trends Cell Biol. 2012 Mar;22(3):125-32
pubmed: 22260888
Radiother Oncol. 2021 Apr;157:106-113
pubmed: 33515670
BMJ. 2010 Jan 14;340:b5349
pubmed: 20075151
Biomed Pharmacother. 2015 Apr;71:185-9
pubmed: 25960234
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):813-9
pubmed: 22975608
World J Biol Chem. 2015 Aug 26;6(3):162-208
pubmed: 26322174
Cancer Gene Ther. 2014 Feb;21(2):54-9
pubmed: 24357814
Appl Spectrosc. 2005 Mar;59(3):267-74
pubmed: 15901305
Int J Mol Sci. 2021 Apr 20;22(8):
pubmed: 33924260
Cleve Clin J Med. 2016 Dec;83(12):914-922
pubmed: 27938516
Br J Cancer. 2013 Jan 15;108(1):91-8
pubmed: 23321513
Circ Res. 2017 Jul 21;121(3):282-292
pubmed: 28729453
Bioinformatics. 2013 Mar 1;29(5):661-3
pubmed: 23325622
Front Cardiovasc Med. 2019 May 17;6:65
pubmed: 31157242
Precis Clin Med. 2019 Dec;2(4):270-282
pubmed: 35693876
Radiat Res. 2017 Oct;188(4.2):539-546
pubmed: 28873026
Clin Pharmacol Ther. 2013 Oct;94(4):480-9
pubmed: 23852395
Environ Int. 2021 Jan;146:106235
pubmed: 33157375
Nat Commun. 2019 Feb 27;10(1):959
pubmed: 30814518
Arch Med Res. 2018 Nov;49(8):530-537
pubmed: 30642654
PLoS One. 2020 May 11;15(5):e0232411
pubmed: 32392259
Mol Cell Biochem. 2021 Nov;476(11):4045-4059
pubmed: 34244974
Front Pharmacol. 2018 Aug 17;9:903
pubmed: 30174600
Oncotarget. 2016 Oct 18;7(42):68253-68269
pubmed: 27626168
Cardiovasc Res. 2011 Feb 1;89(2):265-72
pubmed: 20880837
Am J Pathol. 2012 Mar;180(3):929-939
pubmed: 22210479
Arq Bras Cardiol. 2018 Nov;111(5):738-746
pubmed: 30484515
J Biophotonics. 2020 Jul;13(7):e201960173
pubmed: 32162465
Int J Mol Sci. 2022 Feb 16;23(4):
pubmed: 35216284
Int J Mol Sci. 2021 Sep 30;22(19):
pubmed: 34638924
Environ Sci Pollut Res Int. 2021 Apr;28(13):15584-15596
pubmed: 33533004
Radiat Res. 2022 Jan 1;197(1):22-35
pubmed: 33857324
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):20-27
pubmed: 29193905
Radiat Environ Biophys. 2013 Nov;52(4):435-49
pubmed: 23903347
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12445-50
pubmed: 18711141
In Vivo. 2009 Sep-Oct;23(5):779-96
pubmed: 19779115
PLoS One. 2014 Oct 22;9(10):e110269
pubmed: 25337914
Radiat Res. 2004 Nov;162(5):517-26
pubmed: 15624306
J Am Heart Assoc. 2021 Sep 21;10(18):e021686
pubmed: 34482706
Circ Res. 2019 Jun 7;124(12):1760-1777
pubmed: 30982412
Int J Biol Sci. 2019 Aug 8;15(10):2128-2138
pubmed: 31592122
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Mar 5;248:119118
pubmed: 33214105
EMBO J. 2014 Jul 17;33(14):1565-81
pubmed: 24920580
Curr Mol Med. 2012 Jun;12(5):613-24
pubmed: 22452594
Radiat Res. 2003 Oct;160(4):381-407
pubmed: 12968934
Cardiooncology. 2015 Nov 26;1(1):4
pubmed: 33530149
J Cardiovasc Dev Dis. 2019 Sep 23;6(4):
pubmed: 31547577
Oncogene. 2011 Nov 10;30(45):4601-8
pubmed: 21602884